glp-1 news today As the popularity of drugs continues to skyrocket, there has als... | nbc FDA warns Novo Nordisk of

Zhang, GLP-1 receptor agonist-induced diabetic ketoacidosis: A case report, Medicine (Baltimore) , vol

At Unnati Pharmax , we are proud to support this medical revolution by strengthening global medicine supply chains.

A 2025 study in the American Journal of Ophthalmology did not find a significant increase in NAION or ischemic optic neuropathy risk in patients taking semaglutide or GLP-1 medications compared with diabetes or high-BMI control groups

Retrieved from Wharton, S., Blevins, T., Connery, L., et al

Colhoun HM, Lingvay I, Brown PM, Deanfield J, Brown-Frandsen K, Kahn SE, et al

The important signalling role of these hormones in the brain for obesity and type 2 obesity had been first flagged up following the discovery of leptin and later ghrelin